SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Ken Reidy who wrote (547)1/29/1999 9:41:00 PM
From: Dan Spillane  Read Replies (1) | Respond to of 1298
 
Cell Genesys has crucial technology which enables the "targeting" of gene therapy; it's becoming more and more apparent that it isn't just understanding the genes, but getting them accepted in the proper places in the body. Hopefully, Wall Street will begin to understand this.

So they moved the story one night. I wonder if people are going to be stuck short after the confusion?!?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News